Research into Ewing sarcoma is ongoing, with recent advances focusing on targeted therapies and immunotherapies. New drugs that target the specific genetic abnormalities in Ewing sarcoma cells are being developed and tested in clinical trials. Additionally, researchers are exploring the use of CAR-T cell therapy and other immunotherapies to boost the body's immune response against the cancer.
